0001209191-23-059232.txt : 20231219
0001209191-23-059232.hdr.sgml : 20231219
20231219172759
ACCESSION NUMBER: 0001209191-23-059232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231217
FILED AS OF DATE: 20231219
DATE AS OF CHANGE: 20231219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nuss John
CENTRAL INDEX KEY: 0001874108
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 231498614
MAIL ADDRESS:
STREET 1: C/O VENTYX BIOSCIENCES, INC.
STREET 2: 332 ENCINITAS BLVD. SUITE 200
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-17
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001874108
Nuss John
C/O VENTYX BIOSCIENCES, INC.
12790 EL CAMINO REAL, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
Chief Scientific Officer
0
Common Stock
2023-12-17
4
M
0
34931
0.00
A
279746
D
Restricted Stock Units
2023-12-17
4
M
0
34931
0.00
D
Common Stock
34931
69860
D
Stock Option (Right to Buy)
2.14
2023-12-18
4
A
0
181250
0.00
A
2033-12-18
Common Stock
181250
181250
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.
One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following December 18, 2023 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider, as defined in the Company's 2021 Equity Incentive Plan (the "Plan") through each such date.
/s/ Christopher Krueger, as Attorney-in-Fact
2023-12-19